MONIKA VASIC: Open Payments
NPI 1275935132 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,314 in 331 payments from 25 companies in 2025. Trend: 2023 $6,075 · 2024 $6,152 · 2025 $6,314
Food & beverage: $6,314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $1,254 |
| Janssen Biotech, Inc. | 46 | $976 |
| Takeda Pharmaceuticals U.S.A., Inc. | 52 | $882 |
| Madrigal Pharmaceuticals | 32 | $647 |
| Ardelyx, Inc. | 26 | $538 |
| QOL Medical, LLC | 17 | $375 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $245 |
| Phathom Pharmaceuticals, Inc. | 10 | $215 |
| GENZYME CORPORATION | 8 | $176 |
| Celltrion USA Inc. | 11 | $174 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, RINVOQ, IBSRELA, Sucraid, XIFAXAN, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
